Topics

Dyadic International inks agreement with Australia’s Luina Bio

05:45 EDT 30 Apr 2019 | Proactive Investors

Dyadic CEO Mark Emalfarb says the partnership will bring the companies closer to speeding up the development of low-cost biologic medicines

Original Article: Dyadic International inks agreement with Australia’s Luina Bio

NEXT ARTICLE

More From BioPortfolio on "Dyadic International inks agreement with Australia’s Luina Bio"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...